Adiponectin Moderates Antidepressant Treatment Outcome in the Combining Medications to Enhance Depression Outcomes Randomized Clinical Trial

BACKGROUND: Major depressive disorder (MDD) is often comorbid with metabolic diseases such as obesity, cardiovascular disease, and type 2 diabetes. A potential link between these disorders is adiponectin, an adipocyte-derived circulating hormone with insulin-sensitizing, anti-inflammatory, and neuro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pers Med Psychiatry
Egile Nagusiak: Furman, Jennifer L., Soyombo, Abigail, Czysz, Andrew H., Jha, Manish K., Carmody, Thomas J., Mason, Brittany L., Scherer, Philipp E., Trivedi, Madhukar H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6408148/
https://ncbi.nlm.nih.gov/pubmed/30859144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pmip.2018.05.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak